- Exchange: EN Paris
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Services
- Sub-Industry: Medical Labs&Testing Srv
Snapshot for BioMerieux (BIM)
| Open: | 63.5000 | Day's Range: | 62.9700 - 64.1500 | Volume: | 37,071 | Bid: | 64.0000 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 63.5000 | 52wk Range: | 53.2500 - 84.0000 | 1-Yr Rtn: | -20.92% | Ask: | 64.1200 |
Key Statistics for BIM
| Current P/E Ratio (ttm) | 15.9900 |
|---|---|
| Estimated P/E (12/2012) | 14.4479 |
| Earnings Per Share (EUR) (ttm) | 4.0100 |
| Est. EPS (EUR) (12/2012) | 4.4380 |
| Est. PEG Ratio | 1.8174 |
| Market Cap (M EUR) | 2,529.77 |
| Shares Outstanding (M) | 39.45 |
| Enterprise Value (M EUR) (ttm) | 2,669.07 |
| Enterprise Value/EBITDA (ttm) | 7.82 |
| Price/Book (mrq) | 2.3085 |
| Price/Sale (ttm) | 1.7717 |
| Dividend Indicated Gross Yield | 1.5284 |
| Next Earnings Announcement | 09/04/2012 |
More BIM Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for BIM
- Operating
- Investing
- Financing (M/EUR)
Company Profile & Key Executives for BIM
bioMerieux designs, develops, manufactures, and markets systems in the field of in vitro diagnostics for medical and industrial applications. The Company is specialized in the diagnosis of infectious diseases and pathologies. bioMerieux is also active in the analysis of food, pharmaceuticals, and environmental samples to determine their microbiological quality.
| Jean-Luc BelingardChairman/CEO | Alexandre MerieuxCOO/Dir:Microbiology Unit |
| Alain PluquetCTO/Dir:Systems & Innovation . | Michel BaguenaultDir:Human Resources |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page